Monographie - Levofolinate calcium

Viimane versioon :
08/05/2024

Levofolinate calcium

Keemiline struktuur

Kaubanduslikud nimed erinevates maades

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Calc Levof	Itaalia
Calcium levofolinat	Austria
Elvorine	Belgia, Luksemburg, Maroko, Prantsusmaa
Folaxin	Hispaania
Folinate EG	Belgia
Isovorin	Austria, Hispaania, Island, Kreeka, Rootsi, Soome, Suurbritannia, Taani
Levofolatino de calcio	Portugal
Levofolene	Itaalia

Viited : Levofolinate calcium

	Tüüp	Avaldamine
3	Ajaleht	Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
155	Ajaleht	Trissel LA, Martinez JF, Xu QA. Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium. Am J Health-Syst Pharm 1995 ; 52: 710-715.
1520	Labor	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1914	Labor	Pemetrexed (Alimta®) - Summary of Product Characteristics Eli Lilly 2016
2130	Ajaleht	Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J. Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique. Bull Cancer 1999 ; 86, 11: 946-954.
2181	Ajaleht	Milano G, Renée N. Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique. Bull Cancer 1995 ; 82: 189-195.
2295	Labor	Fosaprepitant (Emend®) - Summary of Product Characteristics Merck Sharp Dohme 2013
2361	Ajaleht	Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L. Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags. J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
2531	Ajaleht	Sanogo S, Silimbani P, Gaggeri R, Masini C. Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags. J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
3369	Labor	Levofolinate de sodium Medac - Résumé des caractéristiques du produits MEDAC France 2011
3523	Labor	Ceftriaxone (Rocephin®) - Summary of Product Characteristics. Roche 2018
3546	Labor	Cefamandole Flavelab - Résumé des caractéristiques du produit Panpharma SA 2007
3619	Labor	Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics Wockhardt 2016
3621	Labor	Phosphate dipotassique - Résumé des caractéristiques du produit Renaudin 2008
3662	Labor	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014
3753	Labor	Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics Cubist Pharmaceuticals 2014
3838	Labor	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3933	Labor	Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit Teva Laboratoire 2015
4154	Labor	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4720	Labor	Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021. Paratek Pharmaceuticals 2021

Mentions Légales